Healthcare provider profile · identity verified

Kelly Pucillo, MD

Family Practice · WAUPACA, WI · NPI 1548200595

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	342	77
Atorvastatin Calcium	Atorvastatin Calcium	341	78
Amlodipine Besylate	Amlodipine Besylate	315	74
Simvastatin	Simvastatin	290	71
Lisinopril	Lisinopril	284	73
Gabapentin	Gabapentin	217	36
Omeprazole	Omeprazole	214	46
Trazodone Hcl	Trazodone Hcl	182	32
Losartan Potassium	Losartan Potassium	160	40
Metoprolol Tartrate	Metoprolol Tartrate	155	34
Potassium Chloride	Potassium Chloride	153	32
Furosemide	Furosemide	149	30
Metoprolol Succinate	Metoprolol Succinate	146	32
Sertraline Hcl	Sertraline Hcl	142	26
Alendronate Sodium	Alendronate Sodium	139	37
Hydrochlorothiazide	Hydrochlorothiazide	120	35
Duloxetine Hcl	Duloxetine Hcl	109	19
Clopidogrel	Clopidogrel Bisulfate	100	16
Metformin Hcl	Metformin Hcl	100	20
Eliquis	Apixaban	92	18
Pantoprazole Sodium	Pantoprazole Sodium	88	18
Allopurinol	Allopurinol	87	15
Fluticasone Propionate	Fluticasone Propionate	87	24
Rosuvastatin Calcium	Rosuvastatin Calcium	82	22
Metformin Hcl Er	Metformin Hcl	80	21
Donepezil Hcl	Donepezil Hcl	73	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	72	13
Buspirone Hcl	Buspirone Hcl	71	17
Fluoxetine Hcl	Fluoxetine Hcl	64	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	suppressed
Pravastatin Sodium	Pravastatin Sodium	60	15
Tamsulosin Hcl	Tamsulosin Hcl	51	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	50	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	13
Diclofenac Sodium	Diclofenac Sodium	47	18
Jardiance	Empagliflozin	47	suppressed
Memantine Hcl	Memantine Hcl	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Levetiracetam	Levetiracetam	40	suppressed
Tramadol Hcl	Tramadol Hcl	40	suppressed
Trulicity	Dulaglutide	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Jantoven	Warfarin Sodium	38	suppressed
Atenolol	Atenolol	37	suppressed
Clonazepam	Clonazepam	36	suppressed
Meloxicam	Meloxicam	36	14
Bumetanide	Bumetanide	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	34	suppressed
Alprazolam	Alprazolam	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Glipizide	Glipizide	30	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Ozempic	Semaglutide	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Glipizide Er	Glipizide	28	suppressed
Lovastatin	Lovastatin	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Baclofen	Baclofen	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Fentanyl	Fentanyl	25	suppressed
Lidocaine	Lidocaine	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Digoxin	Digoxin	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Prednisone	Prednisone	18	12
Triamcinolone Acetonide	Triamcinolone Acetonide	18	16
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Cefdinir	Cefdinir	16	14
Finasteride	Finasteride	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Naproxen	Naproxen	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Cephalexin	Cephalexin	15	11
Chlorthalidone	Chlorthalidone	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Glatiramer Acetate	Glatiramer Acetate	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Famotidine	Famotidine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Humira Pen	Adalimumab	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error